Watchmaker Genomics

Watchmaker Genomics, founded in 2019 and headquartered in Boulder, Colorado, is a biotechnology company specializing in the design and development of precision tools for the life sciences. The company focuses on advanced enzymology to enable breakthrough applications for reading, writing, and editing DNA and RNA. Co-founded by Trey Foskett, Brian Kudlow, and Stephen Picone, Watchmaker Genomics combines expertise in protein engineering and enzyme manufacturing to address demanding quality and performance standards. The company has raised significant funding, including a $40M Series A round in 2022, to expand its clinical sequencing product offerings.

Recent Posts by Watchmaker Genomics

1-20 of 27